AnalystsSteve Seedhouse
Steve Seedhouse's Stock Forecasts

Analyst Ranking
Top 33%
#1735 out of 5296 analysts
Average Return
+3.47%
Win Rate
44%11 out of 25
Risk vs Reward
Poor
Good

Steve Seedhouse's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Apellis Pharmaceuticals IncAPLS
+129.35%$17.89$41.03
2026-03-17 -
2026-05-15
Strong Buy
Apellis Pharmaceuticals IncAPLS
+92.36%$21.33$41.03
2026-01-12 -
2026-05-15
Strong Buy
Apellis Pharmaceuticals IncAPLS
+78.78%$22.95$41.03
2025-07-31 -
2026-05-15
Strong Buy
Camp4 Therapeutics CorpCAMP
+40.60%$2.98$4.19
2025-10-01 -
2026-06-12
Strong Buy
Harrow IncHROW
+26.20%$29.83$37.64
2026-05-12 -
2026-06-12
Strong Buy

Steve Seedhouse Analyst Color

Get additional color on Steve Seedhouse's coverage of popular stocks

Steve Seedhouse's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Aligos Therapeutics IncALGS
1Strong Buy$20.00+278.79%Initiates Coverage On
23 days ago
Harrow IncHROW
3Strong Buy$88.00+133.79%Maintains
a month ago
Inflarx NvIFRX
1Strong Buy$4.00+150.00%Maintains
a month ago
Abcellera Biologics IncABCL
1Strong Buy$7.00+33.59%Initiates Coverage On
a month ago
Viking Therapeutics IncVKTX
1Strong Buy$100.00+247.83%Maintains
a month ago
Opus Genetics IncIRD
1Strong Buy$15.00+271.29%Initiates Coverage On
2 months ago
Surrozen IncSRZN
2Strong Buy$40.00+71.01%Reiterates
3 months ago
Apellis Pharmaceuticals IncAPLS
3Strong Buy$31.00-24.45%Maintains
3 months ago
Korro Bio IncKRRO
2Strong Buy$22.00+89.49%Maintains
3 months ago
Belite Bio IncBLTE
2Strong Buy$266.00+92.53%Maintains
3 months ago
Wave Life Sciences LtdWVE
2Strong Buy$41.00+598.47%Maintains
4 months ago
Xencor IncXNCR
2Strong Buy$42.00+240.63%Maintains
7 months ago
Innoviva IncINVA
2Strong Buy$31.00+36.32%Maintains
7 months ago
Camp4 Therapeutics CorpCAMP
1Strong Buy$7.00+67.06%Initiates Coverage On
8 months ago
Tvardi Therapeutics IncTVRD
1Strong Buy$52.00+1,869.70%Initiates Coverage On
a year ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.